Vimentin silenced by small interfering RNA inhibits glial scar formation in a rat model of acute spinal cord injury

doi:10.12307/2022.619

Abstract

Abstract: BACKGROUND: A barrier with formation of glial scar after spinal cord injury is considered to be harmful for nerve repair.
OBJECTIVE: To explore the influence of small interfering RNA (siRNA)-mediated inhibiting Vimentin on reactive astrocytes and on the formation of glial scar after central nervous system injury.
METHODS: Third-generation astrocytes that grew well were selected and randomized into untransfected group, siRNA-NC group, and siRNA-Vimentin group. We used siRNA interference technology to silence vimentin expression in astrocytes, and Vimentin immunofluorescence staining was conducted at 24 hours after transfection. Cell migration and proliferation were observed through a cell scratch test. Sprague-Dawley rats were randomized into a control group (n=10), in which only the lamina was opened, without damage to the spinal cord; a model group (n=20), in which a spinal cord injury model was prepared, followed by direct injection of saline and empty plasmids into the spinal cord; and a treatment group (n=20), in which the spinal cord injury model was prepared followed by direct injection of Vimentin plasmids intervened with siRNA for 24 hours. Spinal cord continuity and thickness as well as scar adhesion with surrounding tissues were observed at 1 day, 4, and 8 weeks after surgery.
RESULTS AND CONCLUSION: Integral asorbance value of Vimentin by fluorescence immunoassay was lower in the siRNA-Vimentin group than the untransfected and siRNA-NC groups (P < 0.05). The scratched width was larger in the siRNA-Vimentin group than the untransfected and siRNA-NC groups. The spinal cord tissue structure at the injured site was improved in the treatment group, and the range of glial scar formation was smaller in the treatment group than the model group at 4 and 8 weeks after surgery. To conclude, Vimentin has a significant inhibitory effect on the proliferation and migration of reactive astrocytes and inhibits the formation of glial scars after spinal cord injury, providing a favorable microenvironment for axonal regeneration and nerve function recovery after spinal cord injury.

Key words: small interfering RNA, Vimentin, reactive astrocyte, glial scar, spinal cord injury

CLC Number:

Li Jianfeng, Zhang Shulian, Yan Jinyu, Li jiayi, Jin Zhao, Deng Qi. Vimentin silenced by small interfering RNA inhibits glial scar formation in a rat model of acute spinal cord injury[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(20): 3190-3195.

Figures/Tables 10

References

[1] KHORASANIZADEH M, YOUSEFIFARD M, ESKIAN M, et al. Neurological recovery following traumatic spinal cord injury: a systematic review and meta-analysis. J Neurosurg Spine. 2019;30:683-699.
[2] FAULKNER JR, HERRMANN JE, WOO MJ, et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci. 2004;24(9):2143-2155.
[3] SULLIVAN PZ, ALBAYAR A, BURRELL JC, et al. Implantation of Engineered Axon Tracts to Bridge Spinal Cord Injury Beyond the Glial Scar in Rats. Tissue Eng Part A. 2021;27(19-20):1264-1274.
[4] BANG M, RYU O, KIM DG, et al. Tenovin-1 Induces Senescence and Decreases Wound-Healing Activity in Cultured Rat Primary Astrocytes. Biomol Ther (Seoul). 2019;27(3):283-289.
[5] TAN X, CHEN C, ZHU Y, et al. Proteotoxic Stress Desensitizes TGF-beta Signaling Through Receptor Downregulation in Retinal Pigment Epithelial Cells. Curr Mol Med. 2017;17(3):189-199.
[6] WILSON S, FREDERICKS DC, SAFAYI S, et al. Ovine Hemisection Model of Spinal Cord Injury. J Invest Surg. 2021;34(4):380-392.
[7] ALIZADEH A, DYCK SM, KARIMI-ABDOLREZAEE S. Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms. Front Neurol. 2019;10:282.
[8] AHUJA CS, MOTHE A, KHAZAEI M, et al. The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury. Stem Cells Transl Med. 2020;9(12):1509-1530.
[9] LI X, LI M, TIAN L, et al. Reactive Astrogliosis: Implications in Spinal Cord Injury Progression and Therapy. Oxid Med Cell Longev. 2020; 2020:9494352.
[10] KIM YH, HA KY, KIM SI. Spinal Cord Injury and Related Clinical Trials. Clin Orthop Surg. 2017;9(1):1-9.
[11] ZHENG Y, MAO YR, YUAN TF, et al. Multimodal treatment for spinal cord injury: a sword of neuroregeneration upon neuromodulation. Neural Regen Res. 2020;15(8):1437-1450.
[12] YILMAZ T, KAPTANOĞLU E. Current and future medical therapeutic strategies for the functional repair of spinal cord injury. World J Orthop. 2015;6(1):42-55.
[13] WILSON JR, TETREAULT LA, KWON BK, et al. Timing of Decompression in Patients With Acute Spinal Cord Injury: A Systematic Review. Global Spine J. 2017;7(3 Suppl):95S-115S.
[14] CEKANAVICIUTE E, BUCKWALTER MS. Astrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases. Neurotherapeutics. 2016;13(4):685-701.
[15] TRAN AP, WARREN PM, SILVER J. The Biology of Regeneration Failure and Success After Spinal Cord Injury. Physiol Rev. 2018;98(2):881-917.
[16] DYCK S, KATARIA H, ALIZADEH A, et al. Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury. J Neuroinflammation. 2018;15(1):90.
[17] WANG GY, CHENG ZJ, YUAN PW, et al. Olfactory ensheathing cell transplantation alters the expression of chondroitin sulfate proteoglycans and promotes axonal regeneration after spinal cord injury. Neural Regen Res. 2021;16(8):1638-1644.
[18] ANJUM A, YAZID MD, FAUZI DAUD M, et al. Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms. Int J Mol Sci. 2020;21(20):7533.
[19] ORR MB, GENSEL JC. Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses. Neurotherapeutics. 2018;15(3):541-553.
[20] WILLIAMS A, PIATON G, LUBETZKI C. Astrocytes--friends or foes in multiple sclerosis? Glia. 2007;55(13):1300-1312.
[21] LENT R, AZEVEDO FA, ANDRADE-MORAES CH, et al. How many neurons do you have? Some dogmas of quantitative neuroscience under revision. Eur J Neurosci. 2012;35(1):1-9.
[22] LOSHAJ-SHALA A, COLZANI M, BREZOVSKA K, et al. Immunoproteomic identification of antigenic candidate Campylobacter jejuni and human peripheral nerve proteins involved in Guillain-Barré syndrome. J Neuroimmunol. 2018;317:77-83.
[23] TESHIGAWARA K, KUBOYAMA T, SHIGYO M, et al. A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte-secreted vimentin. Br J Pharmacol. 2013;168(4):903-919.
[24] DANIELSSON F, PETERSON MK, CALDEIRA ARAÚJO H, et al. Vimentin Diversity in Health and Disease. Cells. 2018;7(10):147.
[25] RAGINOV IS, CHELYSHEV IUA, SHAGIDULLIN TF. Interaction of sensory neurons and satellite cells during stimulation of the nerve regeneration. Morfologiia. 2002;122(4):37-39.
[26] BAUMANN HJ, MAHAJAN G, HAM TR, et al. Softening of the chronic hemi-section spinal cord injury scar parallels dysregulation of cellular and extracellular matrix content. J Mech Behav Biomed Mater. 2020; 110:103953.
[27] DERVAN AG, ROBERTS BL. Reaction of spinal cord central canal cells to cord transection and their contribution to cord regeneration. J Comp Neurol. 2003;458(3):293-306.
[28] TRUJILLO-CENÓZ O, REHERMANN MI, MACIEL C, et al. The ependymal cell cytoskeleton in the normal and injured spinal cord of mice. J Neurosci Res. 2021;99(10):2592-2609.
[29] POLCYN R, CAPONE M, MATZELLE D, et al. Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury. Neurochem Int. 2020;139:104788.
[30] IZMIRYAN A, LI Z, NOTHIAS F, et al. Inactivation of vimentin in satellite glial cells affects dorsal root ganglion intermediate filament expression and neuronal axon growth in vitro. Mol Cell Neurosci. 2021; 115:103659.
[31] HOFSTETTER CP, SCHWARZ EJ, HESS D, et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A. 2002;99(4):2199-2204.
[32] JIN LQ, JOHN BH, HU J, et al. Activated Erk Is an Early Retrograde Signal After Spinal Cord Injury in the Lamprey. Front Neurosci. 2020; 14:580692.